Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT
A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist.
AbbVie Inc. (NYSE:ABBV) reported positive fiscal Q1 2025 results that support the optimistic outlook, with adjusted diluted EPS reaching $2.46, experiencing a 6.5% growth.
The company also reported $13.343 billion in net revenue for the first quarter of 2025, reflecting an 8.4% growth on a reported basis or 9.8% on an operational basis.
AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions.
While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
27 minutes ago
- Business Insider
Goldman Sachs Sticks to Their Buy Rating for Nike (NKE)
Goldman Sachs analyst Brooke Roach maintained a Buy rating on Nike yesterday and set a price target of $85.00. The company's shares closed yesterday at $74.02. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Roach covers the Consumer Cyclical sector, focusing on stocks such as Kontoor Brands, Kohl's, and Nike. According to TipRanks, Roach has an average return of 6.0% and a 51.63% success rate on recommended stocks. In addition to Goldman Sachs, Nike also received a Buy from TR | OpenAI – 4o's Jax Loafter in a report issued on July 18. However, yesterday, Stifel Nicolaus reiterated a Hold rating on Nike (NYSE: NKE). Based on Nike's latest earnings release for the quarter ending May 31, the company reported a quarterly revenue of $11.1 billion and a net profit of $211 million. In comparison, last year the company earned a revenue of $12.61 billion and had a net profit of $1.5 billion
Business Insider
27 minutes ago
- Business Insider
Goldman Sachs Remains a Hold on Yeti Holdings (YETI)
In a report released yesterday, Brooke Roach from Goldman Sachs maintained a Hold rating on Yeti Holdings, with a price target of $32.00. The company's shares closed yesterday at $35.83. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Roach covers the Consumer Cyclical sector, focusing on stocks such as Kontoor Brands, Kohl's, and Nike. According to TipRanks, Roach has an average return of 6.0% and a 51.63% success rate on recommended stocks. In addition to Goldman Sachs, Yeti Holdings also received a Hold from UBS's Peter Grom in a report issued on July 17. However, on the same day, TR | OpenAI – 4o reiterated a Buy rating on Yeti Holdings (NYSE: YETI).
Business Insider
27 minutes ago
- Business Insider
VF (VFC) Receives a Hold from Goldman Sachs
In a report released yesterday, Brooke Roach from Goldman Sachs maintained a Hold rating on VF, with a price target of $11.50. The company's shares closed yesterday at $12.45. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Roach is a 4-star analyst with an average return of 6.0% and a 51.63% success rate. Roach covers the Consumer Cyclical sector, focusing on stocks such as Kontoor Brands, Kohl's, and Nike. In addition to Goldman Sachs, VF also received a Hold from TR | OpenAI – 4o's Vince Stitcher in a report issued on July 12. However, on July 16, Williams Trading downgraded VF (NYSE: VFC) to a Sell. Based on VF's latest earnings release for the quarter ending March 29, the company reported a quarterly revenue of $2.14 billion and a GAAP net loss of $150.79 million. In comparison, last year the company earned a revenue of $2.37 billion and had a GAAP net loss of $418.31 million Based on the recent corporate insider activity of 31 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VFC in relation to earlier this year. Most recently, in May 2025, Richard Carucci, a Director at VFC bought 50,000.00 shares for a total of $602,500.00.
